article thumbnail

Jaguar Health out-licenses plant-based drug for schizophrenia

Drug Discovery World

Jaguar Health’s out-licensing agreement with Magdalena Biosciences to develop novel, natural prescription medicines derived from plants for mental health indications, has been expanded. ” The US schizophrenia market is projected to grow to $8.06 billion by 2030, according to a market research report by Market Research Future.

Licensing 148
article thumbnail

Renaissance Pharma licenses Hu14.18 for neuroblastoma

Drug Discovery World

Renaissance Pharma has announced its first development programme focused on Hu14.18, a humanised anti-GD2 monoclonal antibody (mAb), licensed from St Jude Children’s Research Hospital for the treatment of newly diagnosed high-risk neuroblastoma. ” The post Renaissance Pharma licenses Hu14.18

Licensing 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Tay licenses oral BET inhibitor to VYNE Therapeutics

Drug Discovery World

UK company Tay Therapeutics has entered into an exclusive license agreement with US biotech VYNE Therapeutics for its oral bromodomain and extra-terminal domain (BET) inhibitor TAY-B2. Tay Therapeutics out-licensed its topical pan-BET inhibitor to VYNE for £16m in upfront and milestone payments in 2021.

Licensing 130
article thumbnail

Ubiquigent obtains exclusive license for UbiSite technology

Drug Discovery World

UK-based company Ubiquigent has signed an exclusive license with the University of Southern Denmark for its UbiSite technology. We are pleased to be licensing our UbiSite technology to Ubiquigent, a company that is strongly positioned to facilitate DUB focused drug discovery programmes and power advances in this largely unexploited field.”.

Licensing 130
article thumbnail

Takeda nabs option to license Alzheimer’s immunotherapies from AC Immune

BioPharma Drive: Drug Pricing

The deal — worth $100 million up front and potentially billions more later on — gives Takeda an exclusive option to license an Alzheimer’s vaccine and other “active immunotherapies.”

article thumbnail

Teens with Anxiety, Mood Disorders Less Likely to Get Driver's License

Drugs.com

WEDNESDAY, April 10, 2024 -- Teenagers suffering from anxiety, depression or bipolar disorder are likely to have a tougher time getting their driver’s license, a new study finds.Teens and young adults with these types of mood disorders are 30%.

article thumbnail

List of NIH-Licensed Technologies

Drug Patent Watch

While answering a question for a DrugPatentWatch user, the question arose of technologies the NIH has licensed. It turns out that they keep a list on their website, so I… The post List of NIH-Licensed Technologies appeared first on DrugPatentWatch - Make Better Decisions.